cas 1269291-01-1|| where to buy 5-fluoro-1-(pyrimidin-2-yl)-1H-pyrazole-4-carbonitrile

Nom du produit:5-fluoro-1-(pyrimidin-2-yl)-1H-pyrazole-4-carbonitrile

IUPAC Name:5-fluoro-1-(pyrimidin-2-yl)-1H-pyrazole-4-carbonitrile

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM165786-1g	in stock	ȖŪƚ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1269291-01-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1269291-01-1; Formule moléculaire:C8H4FN5; Point de fusion:-; Code SMILES:N#CC1=C(F)N(C2=NC=CC=N2)N=C1; Densité:

: Numéro de catalogue:CM165786; Poids moléculaire:189.15; Point d'ébullition:; N° Mdl:MFCD17168524; Stockage:Store at 2-8°C.

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.